HSP90-IN-13 structure
|
Common Name | HSP90-IN-13 | ||
|---|---|---|---|---|
| CAS Number | 2446055-29-2 | Molecular Weight | 483.54 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H21N5O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HSP90-IN-13HSP90-IN-13 (compound 5k) is a highly potent HSP90 pan inhibitor with an IC50 value of 25.07 nM. HSP90-IN-13 has multi-target activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 causes cell cycle arrest at G2/M phase and induces apoptosis of MCF-7 cells through mitochondrial-mediated pathway[1]. |
| Name | HSP90-IN-13 |
|---|
| Description | HSP90-IN-13 (compound 5k) is a highly potent HSP90 pan inhibitor with an IC50 value of 25.07 nM. HSP90-IN-13 has multi-target activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 causes cell cycle arrest at G2/M phase and induces apoptosis of MCF-7 cells through mitochondrial-mediated pathway[1]. |
|---|---|
| Related Catalog | |
| Target |
HSP90:25.07 nM (IC50) Topoisomerase-2:25.85 nM (IC50) EGFR:38.5 nM (IC50) VEGFR-2:126.95 nM (IC50) |
| In Vitro | HSP90-IN-13 (compound 5k) arrests the cell cycle on MCF-7 at a G2/M phase by 35.06% and induced apoptosis by 19.82%[1]. HSP90-IN-13 has anti-proliferative activity against HCT-116, Hela and MCF-7 cell lines with IC50s of 4.47 μM, 7.55 μM and 4.04 μM, respectively[1]. HSP90-IN-13 has potent multi-target inhibitory activities against EGFR, VEGFR-2 and Topoisomerase-2 with IC50 values of 38.5 nM, 126.95 nM and 25.85 nM, respectively[1]. |
| References |
| Molecular Formula | C26H21N5O3S |
|---|---|
| Molecular Weight | 483.54 |